Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
GOLDMAN SACHS GROUP INC
> AKBA
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 03/31/2023 | Akebia Therapeutics, Inc. | AKBA | 67,844 | -395,966 | 38,020,000 | 37,873,000 | $560.40 |
| 09/30/2022 | Akebia Therapeutics, Inc. | AKBA | 463,810 | 122,264 | 147,000 | 27,000 | $0.32 |
| 06/30/2022 | Akebia Therapeutics, Inc. | AKBA | 341,546 | -1,805,617 | 120,000 | -4,732,000 | $0.35 |
| 12/31/2021 | Akebia Therapeutics, Inc. | AKBA | 2,147,163 | 1,632,905 | 4,852,000 | 3,370,000 | $2.26 |
| 09/30/2021 | Akebia Therapeutics, Inc. | AKBA | 514,258 | -2,593,278 | 1,482,000 | -10,295,000 | $2.88 |
| 06/30/2021 | Akebia Therapeutics, Inc. | AKBA | 3,107,536 | -494,626 | 11,777,000 | 1,691,000 | $3.79 |
| 12/31/2020 | Akebia Therapeutics, Inc. | AKBA | 3,602,162 | 2,150,016 | 10,086,000 | 6,441,000 | $2.80 |
| 09/30/2020 | Akebia Therapeutics, Inc. | AKBA | 1,452,146 | 314,613 | 3,645,000 | -11,803,000 | $2.51 |
| 06/30/2020 | Akebia Therapeutics, Inc. | AKBA | 1,137,533 | 365,281 | 15,448,000 | 9,594,000 | $13.58 |
| 03/31/2020 | Akebia Therapeutics, Inc. | AKBA | 772,252 | 23,866 | 5,854,000 | 1,124,000 | $7.58 |
| 12/31/2019 | Akebia Therapeutics, Inc. | AKBA | 748,386 | 439,972 | 4,730,000 | 3,521,000 | $6.32 |
| 09/30/2019 | Akebia Therapeutics, Inc. | AKBA | 308,414 | 53,468 | 1,209,000 | -25,000 | $3.92 |
| 06/30/2019 | Akebia Therapeutics, Inc. | AKBA | 254,946 | -106,327 | 1,234,000 | -1,725,000 | $4.84 |
| 03/31/2019 | Akebia Therapeutics, Inc. | AKBA | 361,273 | -7,230 | 2,959,000 | 922,000 | $8.19 |
| 12/31/2018 | Akebia Therapeutics, Inc. | AKBA | 368,503 | 244,878 | 2,037,000 | 945,000 | $5.53 |
| 09/30/2018 | Akebia Therapeutics, Inc. | AKBA | 123,625 | -184,354 | 1,092,000 | -1,982,000 | $8.83 |
| 06/30/2018 | Akebia Therapeutics, Inc. | AKBA | 307,979 | -375,941 | 3,074,000 | -7,096,000 | $9.98 |
| 12/31/2017 | Akebia Therapeutics, Inc. | AKBA | 683,920 | 43,923 | 10,170,000 | -2,419,000 | $14.87 |
| 09/30/2017 | Akebia Therapeutics, Inc. | AKBA | 639,997 | 348,107 | 12,589,000 | 8,394,000 | $19.67 |
| 06/30/2017 | Akebia Therapeutics, Inc. | AKBA | 291,890 | 242,613 | 4,195,000 | 3,742,000 | $14.37 |
| 03/31/2017 | Akebia Therapeutics, Inc. | AKBA | 49,277 | 608 | 453,000 | -54,000 | $9.19 |
| 12/31/2016 | Akebia Therapeutics, Inc. | AKBA | 48,669 | 30,513 | 507,000 | 343,000 | $10.42 |
| 09/30/2016 | Akebia Therapeutics, Inc. | AKBA | 18,156 | 18,156 | 164,000 | 164,000 | $9.03 |
| 06/30/2016 | Akebia Therapeutics, Inc. | AKBA | 13,780 | -447 | 103,000 | -25,000 | $7.47 |
| 03/31/2016 | Akebia Therapeutics, Inc. | AKBA | 14,227 | 2,616 | 128,000 | -22,000 | $9.00 |
| 12/31/2015 | Akebia Therapeutics, Inc. | AKBA | 11,611 | 11,611 | 150,000 | 150,000 | $12.92 |
| 09/30/2015 | Akebia Therapeutics, Inc. | AKBA | 0 | -17,616 | 0 | -181,000 | |
| 06/30/2015 | Akebia Therapeutics, Inc. | AKBA | 17,616 | 17,616 | 181,000 | 181,000 | $10.27 |
| << Prev Next >> |
|